Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M139Revenue $M2.1Net Margin (%)-555.3Z-Score-4.4
Enterprise Value $M118EPS $-0.5Operating Margin %-561.4F-Score4
P/E(ttm))0Cash Flow Per Share $-0.4Pre-tax Margin (%)-560.8Higher ROA y-yN
Price/Book7.610-y EBITDA Growth Rate %0Quick Ratio9.9Cash flow > EarningsY
Price/Sales33.75-y EBITDA Growth Rate %0Current Ratio9.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-73.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-154.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M29.3ROI % (ttm)-76.2Gross Margin Increase y-yN

Gurus Latest Trades with PSDV

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

PSDV is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


PSDV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ashton PaulPresident & CEO 2014-08-01Sell10,000$4.378.92 view
Ashton PaulPresident & CEO 2014-07-01Sell10,000$4.3210.19 view
Ashton PaulPresident & CEO 2014-06-19Sell7,000$419 view
Ashton PaulPresident & CEO 2014-06-17Sell7,700$419 view
Freedman LoriVP Corp. Affairs, GC and Sec 2014-06-17Sell7,900$419 view
Freedman LoriVP Corp. Affairs, GC and Sec 2014-06-13Sell11,700$4.0218.41 view
Ashton PaulPresident & CEO 2014-06-13Sell11,800$4.0218.41 view
Ashton PaulPresident & CEO 2014-05-05Sell3,500$4.0118.7 view
Freedman LoriVP Corp. Affairs, GC and Sec 2014-05-05Sell3,500$4.0118.7 view
Hopper PaulDirector 2012-10-01Buy10,000$1.68183.33 view

Press Releases about PSDV :

    Quarterly/Annual Reports about PSDV:

    News about PSDV:

    Articles On GuruFocus.com
    pSivida Ltd. Reports Operating Results (10-Q) Feb 10 2011 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 09 2010 
    pSivida Ltd. Reports Operating Results (10-K) Sep 27 2010 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 12 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 13 2009 
    pSivida Ltd. Reports Operating Results (10-K) Sep 25 2009 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2009 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 11 2009 
    pSivida Corp. Reports Results for the Second Quarter Ended December 31, 2008; Iluvien™ NDA filing Feb 11 2009 

    More From Other Websites
    pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization... Jul 31 2014
    4:06 pm pSivida reports ILUVIEN for chronic diabetic macular edema receives marketing authorization... Jul 31 2014
    pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization... Jul 31 2014
    pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization... Jul 31 2014
    pSivida Announces ILUVIEN® Receives Marketing Authorization in Norway and Approval for... Jul 28 2014
    pSivida Announces ILUVIEN® Receives Marketing Authorization in Norway and Approval for... Jul 28 2014
    pSivida moves to marketing authorization national phase in 10 more EU countries Jun 30 2014
    pSivida Corp. Reports Positive Regulatory Outcome for ILUVIEN®; Moves to National Phase for... Jun 30 2014
    pSivida Corp. Reports Positive Regulatory Outcome for ILUVIEN®; Moves to National Phase for... Jun 30 2014
    pSivida: Incredible Upside Potential With Limited Risk Jun 09 2014
    PSIVIDA CORP. Financials May 21 2014
    High option volume stocks: INO NI DKS KOL PSDV May 20 2014
    pSivida's (PSDV) CEO Paul Ashton on Q3 2014 Results - Earnings Call Transcript May 14 2014
    PSIVIDA CORP. Files SEC form 10-Q, Quarterly Report May 14 2014
    pSivida plans to seek U.S. approval for Medidur for posterior uveitis May 13 2014
    pSivida (PSDV) Q3 2014 Results - Earnings Call Webcast May 13 2014
    PSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 13 2014
    pSivida reports Q3 EPS (8c), consensus (15c) May 13 2014
    pSivida Corp. Reports Third Quarter 2014 Results May 13 2014
    pSivida Corp. Reports Third Quarter 2014 Results May 13 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK